Clinical significance of residual viremia detected by two real-time PCR assays for response-guided therapy of HCV genotype 1 infection
- 13 January 2014
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (5) , 913-919
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Hepatitis C genotype 1 virus with low viral load and rapid virologic response to peginterferon/ribavirin obviates a protease inhibitorHepatology, 2014
- A Small Percentage of Patients With Hepatitis C Receive Triple Therapy With Boceprevir or TelaprevirClinical Gastroenterology and Hepatology, 2013
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus InfectionNew England Journal of Medicine, 2011
- An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver DiseasesHepatology, 2011
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infectionJournal of Hepatology, 2011
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2011
- Telaprevir for Retreatment of HCV InfectionNew England Journal of Medicine, 2011
- Boceprevir for Untreated Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2011
- Boceprevir for Previously Treated Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2011
- Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α-2a (40 kd)/ribavirin therapyHepatology, 2006